Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-20

FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s quinapril and hydrochlorothiazide 10/12.5 as an original ANDA (with similar products 20/12.5 and 20/25) for the treatment of hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 (Quinapril and Hydrochlorothiazide)
  • QUINAPRIL AND HYDROCHLOROTHIAZIDE 20/12.5 (Quinapril and Hydrochlorothiazide)
  • QUINAPRIL AND HYDROCHLOROTHIAZIDE 20/25 (Quinapril and Hydrochlorothiazide)

Snippet

ORIG AP for QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 (QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5)